nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Rales—Thalidomide—leprosy	0.0444	0.0444	CcSEcCtD
Remifentanil—Electrolyte imbalance—Thalidomide—leprosy	0.0436	0.0436	CcSEcCtD
Remifentanil—Pericarditis—Thalidomide—leprosy	0.0421	0.0421	CcSEcCtD
Remifentanil—Cerebral ischaemia—Thalidomide—leprosy	0.0377	0.0377	CcSEcCtD
Remifentanil—Lymphopenia—Thalidomide—leprosy	0.0356	0.0356	CcSEcCtD
Remifentanil—Nystagmus—Thalidomide—leprosy	0.0255	0.0255	CcSEcCtD
Remifentanil—Pleural effusion—Thalidomide—leprosy	0.0238	0.0238	CcSEcCtD
Remifentanil—Nasopharyngitis—Dapsone—leprosy	0.0231	0.0231	CcSEcCtD
Remifentanil—Myocardial ischaemia—Thalidomide—leprosy	0.0227	0.0227	CcSEcCtD
Remifentanil—Apnoea—Thalidomide—leprosy	0.0215	0.0215	CcSEcCtD
Remifentanil—Musculoskeletal stiffness—Thalidomide—leprosy	0.0203	0.0203	CcSEcCtD
Remifentanil—Oliguria—Thalidomide—leprosy	0.0198	0.0198	CcSEcCtD
Remifentanil—Dyskinesia—Thalidomide—leprosy	0.0194	0.0194	CcSEcCtD
Remifentanil—Leukocytosis—Thalidomide—leprosy	0.0194	0.0194	CcSEcCtD
Remifentanil—Atrioventricular block—Thalidomide—leprosy	0.0188	0.0188	CcSEcCtD
Remifentanil—Hyperkalaemia—Thalidomide—leprosy	0.0179	0.0179	CcSEcCtD
Remifentanil—Pharyngitis—Dapsone—leprosy	0.0177	0.0177	CcSEcCtD
Remifentanil—Pulmonary oedema—Thalidomide—leprosy	0.0162	0.0162	CcSEcCtD
Remifentanil—Erythema—Dapsone—leprosy	0.0156	0.0156	CcSEcCtD
Remifentanil—Amnesia—Thalidomide—leprosy	0.0141	0.0141	CcSEcCtD
Remifentanil—Atrial fibrillation—Thalidomide—leprosy	0.014	0.014	CcSEcCtD
Remifentanil—Visual disturbance—Thalidomide—leprosy	0.014	0.014	CcSEcCtD
Remifentanil—Cough—Dapsone—leprosy	0.0136	0.0136	CcSEcCtD
Remifentanil—Cardiac arrest—Thalidomide—leprosy	0.0126	0.0126	CcSEcCtD
Remifentanil—Tachycardia—Dapsone—leprosy	0.0124	0.0124	CcSEcCtD
Remifentanil—Hypokalaemia—Thalidomide—leprosy	0.012	0.012	CcSEcCtD
Remifentanil—Dysphagia—Thalidomide—leprosy	0.0114	0.0114	CcSEcCtD
Remifentanil—Bronchospasm—Thalidomide—leprosy	0.0112	0.0112	CcSEcCtD
Remifentanil—Bronchitis—Thalidomide—leprosy	0.011	0.011	CcSEcCtD
Remifentanil—Hyperglycaemia—Thalidomide—leprosy	0.0103	0.0103	CcSEcCtD
Remifentanil—Pneumonia—Thalidomide—leprosy	0.0102	0.0102	CcSEcCtD
Remifentanil—Body temperature increased—Dapsone—leprosy	0.01	0.01	CcSEcCtD
Remifentanil—Renal failure—Thalidomide—leprosy	0.01	0.01	CcSEcCtD
Remifentanil—Sweating—Thalidomide—leprosy	0.00977	0.00977	CcSEcCtD
Remifentanil—Haematuria—Thalidomide—leprosy	0.00972	0.00972	CcSEcCtD
Remifentanil—Bradycardia—Thalidomide—leprosy	0.00931	0.00931	CcSEcCtD
Remifentanil—Pharyngitis—Thalidomide—leprosy	0.00908	0.00908	CcSEcCtD
Remifentanil—Visual impairment—Thalidomide—leprosy	0.00882	0.00882	CcSEcCtD
Remifentanil—Cardiac disorder—Thalidomide—leprosy	0.00849	0.00849	CcSEcCtD
Remifentanil—Angiopathy—Thalidomide—leprosy	0.0083	0.0083	CcSEcCtD
Remifentanil—Immune system disorder—Thalidomide—leprosy	0.00826	0.00826	CcSEcCtD
Remifentanil—Mediastinal disorder—Thalidomide—leprosy	0.00824	0.00824	CcSEcCtD
Remifentanil—Chills—Thalidomide—leprosy	0.00821	0.00821	CcSEcCtD
Remifentanil—Arrhythmia—Thalidomide—leprosy	0.00817	0.00817	CcSEcCtD
Remifentanil—Vomiting—Dapsone—leprosy	0.00807	0.00807	CcSEcCtD
Remifentanil—Headache—Dapsone—leprosy	0.00795	0.00795	CcSEcCtD
Remifentanil—Nausea—Dapsone—leprosy	0.00754	0.00754	CcSEcCtD
Remifentanil—Tremor—Thalidomide—leprosy	0.00746	0.00746	CcSEcCtD
Remifentanil—Anaemia—Thalidomide—leprosy	0.00736	0.00736	CcSEcCtD
Remifentanil—Agitation—Thalidomide—leprosy	0.00732	0.00732	CcSEcCtD
Remifentanil—Syncope—Thalidomide—leprosy	0.00714	0.00714	CcSEcCtD
Remifentanil—Loss of consciousness—Thalidomide—leprosy	0.007	0.007	CcSEcCtD
Remifentanil—Cough—Thalidomide—leprosy	0.00695	0.00695	CcSEcCtD
Remifentanil—Convulsion—Thalidomide—leprosy	0.0069	0.0069	CcSEcCtD
Remifentanil—Hypertension—Thalidomide—leprosy	0.00688	0.00688	CcSEcCtD
Remifentanil—Anxiety—Thalidomide—leprosy	0.00676	0.00676	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00673	0.00673	CcSEcCtD
Remifentanil—Dry mouth—Thalidomide—leprosy	0.00663	0.00663	CcSEcCtD
Remifentanil—Confusional state—Thalidomide—leprosy	0.00655	0.00655	CcSEcCtD
Remifentanil—Oedema—Thalidomide—leprosy	0.0065	0.0065	CcSEcCtD
Remifentanil—Shock—Thalidomide—leprosy	0.00639	0.00639	CcSEcCtD
Remifentanil—Nervous system disorder—Thalidomide—leprosy	0.00637	0.00637	CcSEcCtD
Remifentanil—Thrombocytopenia—Thalidomide—leprosy	0.00636	0.00636	CcSEcCtD
Remifentanil—Tachycardia—Thalidomide—leprosy	0.00634	0.00634	CcSEcCtD
Remifentanil—Skin disorder—Thalidomide—leprosy	0.00631	0.00631	CcSEcCtD
Remifentanil—Hyperhidrosis—Thalidomide—leprosy	0.00628	0.00628	CcSEcCtD
Remifentanil—Hypotension—Thalidomide—leprosy	0.00607	0.00607	CcSEcCtD
Remifentanil—Paraesthesia—Thalidomide—leprosy	0.00584	0.00584	CcSEcCtD
Remifentanil—Dyspnoea—Thalidomide—leprosy	0.00579	0.00579	CcSEcCtD
Remifentanil—Somnolence—Thalidomide—leprosy	0.00578	0.00578	CcSEcCtD
Remifentanil—Dyspepsia—Thalidomide—leprosy	0.00572	0.00572	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Thalidomide—leprosy	0.00561	0.00561	CcSEcCtD
Remifentanil—Constipation—Thalidomide—leprosy	0.00556	0.00556	CcSEcCtD
Remifentanil—Pain—Thalidomide—leprosy	0.00556	0.00556	CcSEcCtD
Remifentanil—Feeling abnormal—Thalidomide—leprosy	0.00536	0.00536	CcSEcCtD
Remifentanil—Urticaria—Thalidomide—leprosy	0.00516	0.00516	CcSEcCtD
Remifentanil—Body temperature increased—Thalidomide—leprosy	0.00514	0.00514	CcSEcCtD
Remifentanil—Hypersensitivity—Thalidomide—leprosy	0.00479	0.00479	CcSEcCtD
Remifentanil—Pruritus—Thalidomide—leprosy	0.0046	0.0046	CcSEcCtD
Remifentanil—Diarrhoea—Thalidomide—leprosy	0.00445	0.00445	CcSEcCtD
Remifentanil—Dizziness—Thalidomide—leprosy	0.0043	0.0043	CcSEcCtD
Remifentanil—Vomiting—Thalidomide—leprosy	0.00413	0.00413	CcSEcCtD
Remifentanil—Rash—Thalidomide—leprosy	0.0041	0.0041	CcSEcCtD
Remifentanil—Dermatitis—Thalidomide—leprosy	0.00409	0.00409	CcSEcCtD
Remifentanil—Headache—Thalidomide—leprosy	0.00407	0.00407	CcSEcCtD
Remifentanil—Nausea—Thalidomide—leprosy	0.00386	0.00386	CcSEcCtD
